Hubei Biocause Heilen Pharmaceutical Co Ltd Class A 301211
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥14.80
- Day Range
- ¥14.99–15.77
- 52-Week Range
- ¥13.63–26.98
- Bid/Ask
- ¥15.46 / ¥15.47
- Market Cap
- ¥4.46 Bil
- Volume/Avg
- 6.1 Mil / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 28.24
- Price/Sales
- 8.88
- Dividend Yield (Trailing)
- 3.10%
- Dividend Yield (Forward)
- 3.10%
- Total Yield
- 3.10%
Company Profile
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,012
- Website
- http://www.biocause.com
Comparables
Valuation
|
Metric
|
301211
|
002773
|
301281
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.24 | 15.11 | 59.70 |
Price/Book Value | 1.95 | 2.20 | 1.76 |
Price/Sales | 8.88 | 4.13 | 5.08 |
Price/Cash Flow | 30.89 | 12.82 | 22.92 |
Price/Earnings
301211
002773
301281
Financial Strength
|
Metric
|
301211
|
002773
|
301281
|
|---|---|---|---|
Quick Ratio | 13.43 | 7.98 | 5.53 |
Current Ratio | 14.97 | 8.68 | 6.72 |
Interest Coverage | 292.62 | — | — |
Quick Ratio
301211
002773
301281
Profitability
|
Metric
|
301211
|
002773
|
301281
|
|---|---|---|---|
Return on Assets (Normalized) | 5.03% | 13.96% | 2.91% |
Return on Equity (Normalized) | 5.42% | 15.26% | 3.20% |
Return on Invested Capital (Normalized) | 3.04% | 14.61% | 2.91% |
Return on Assets
301211
002773
301281
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Wgnvgmxxyw | Bygtt | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Srmxbhdj | Lncxr | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Wtjsyzqv | Jcdc | $48.4 Bil | |||
| Viatris Inc
VTRS
| Wwsnlxj | Zqwm | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ntywlpvt | Dkc | $13.5 Bil | |||
| Catalent Inc
CTLT
| Wcvnsrt | Qxfrwyz | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Srnjbxqd | Mwwgtv | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Clllgkh | Jrk | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Ktmnqzvlcg | Qplb | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Bsgmflk | Rgs | $2.3 Bil |
United States